According to a recent press release, zasocitinib, an oral TYK2 inhibitor, is effective in improving skin clearance for psoriasis patients in hard-to-treat areas with once-daily treatment.
According to a recent press release, zasocitinib, an oral TYK2 inhibitor, is effective in improving skin clearance for psoriasis patients in hard-to-treat areas with once-daily treatment.